undamentalytics Newsletter
Sign in

Myomo, Inc. income statement

In fiscal 2025, Myomo, Inc. reported revenue of $40.9m, up 25.7% on the year before, operating income of −$14.4m (a -35.2% margin) and net income of −$15.6m, or −$0.37 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue12248141619334143
Cost of revenue0111345691414
Gross profit11225101013232730
Research and development12222323576
Selling, general and administrative36101114181819———
Selling and marketing————————122021
General and administrative————————121414
Operating income−3−7−11−11−11−10−11−8−6−14−12
Interest expense———00——————
Income before tax————−12−10−11−8−6−15−14
Income tax00———000010
Net income−4−12−10−11−12−10−11−8−6−16−15
Diluted EPS−$2.58−$7.33−$6.29−$5.20−$0.92−$0.47−$0.38−$0.28−$0.16−$0.37−$0.34
Diluted shares (average)2m2m2m2m13m23m28m29m38m42m42m
EBITDA−3−7−10−11−10−10−10−8−6−14−11

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MYO vs SNWVMYO vs TLSIKRMD vs MYO

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Myomo, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Myomo, Inc.